Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

被引：0

作者：

Sean Duffy

Robert Marron

Helen Voelker

Richard Albert

John Connett

William Bailey

Richard Casaburi

J. Allen Cooper

Jeffrey L. Curtis

Mark Dransfield

MeiLan K. Han

Barry Make

Nathaniel Marchetti

Fernando Martinez

Stephen Lazarus

Dennis Niewoehner

Paul D. Scanlon

Frank Sciurba

Steven Scharf

Robert M. Reed

George Washko

Prescott Woodruff

Charlene McEvoy

Shawn Aaron

Don Sin

Gerard J. Criner

机构：

[1] Lewis Katz School of Medicine at Temple University,Department of Thoracic Medicine and Surgery

[2] University of Minnesota,Department of Thoracic Medicine and Surgery

[3] Denver Health Medical Center,undefined

[4] University of Alabama at Birmingham,undefined

[5] Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center,undefined

[6] University of Michigan Health System,undefined

[7] National Jewish Health,undefined

[8] Weill Cornell Medical College of Cornell University,undefined

[9] Univ of California San Francisco,undefined

[10] Minneapolis VA Medical Center,undefined

[11] Mayo Clinic,undefined

[12] University of Pittsburgh Medical Center,undefined

[13] University of Maryland,undefined

[14] Brigham & Women’s Hospital,undefined

[15] HealthPartners,undefined

[16] The Ottawa Hospital Research Institute,undefined

[17] Providence Heart + Lung Institute,undefined

[18] Temple University School of Medicine,undefined

来源：

Respiratory Research | / 18卷

关键词：

COPD; Exacerbation; Beta-blocker;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers
Kenneth R. Chapman
Robert A. Wise
Benjamin M. Scirica
Deepak L. Bhatt
Sami Z. Daoud
Dan Lythgoe
Esther Garcia Gil
Respiratory Research, 22
[42] Tolerability of beta-blockers in heart failure patients with associated chronic obstructive pulmonary disease - myth or reality?
Dan, G. -A.
Dan, A. R.
Gologanu, D.
Buzea, A.
Dobranici, M.
EUROPEAN HEART JOURNAL, 2007, 28 : 520 - 521
[43] Pseudomonas spp and antibiotics in exacerbation of chronic obstructive pulmonary disease (COPD)
Beghi, G
Pasargiklian, I
Mascheroni, E
Boilini, G
Scarazatti, E
Lusco, G
JOURNAL OF CHEMOTHERAPY, 1995, 7 : 163 - 164
[44] Moxifloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD)
Ewig, S.
INFECTION, 2009, 37 : 21 - 21
[45] NOCARDIA OTITIDISCAVIARUM: A CAUSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EXACERBATION
Bakeer, Mohammad
Chinnappan, Justine
Rode, Geeta D.
AL-Handola, Rami
CHEST, 2023, 164 (04) : 1384A - 1385A
[46] Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
Donaldson, GC
Seemungal, TAR
Bhowmik, A
Wedzicha, JA
THORAX, 2002, 57 (10) : 847 - 852
[47] Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease
Maarten van den Berge
Wim CJ Hop
Thys van der Molen
Jan A van Noord
Jacques PHM Creemers
Ad JM Schreurs
Emiel FM Wouters
Dirkje S Postma
Respiratory Research, 13
[48] Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease
van den Berge, Maarten
Hop, Wim C. J.
van der Molen, Thys
van Noord, Jan A.
Creemers, Jacques P. H. M.
Schreurs, Ad J. M.
Wouters, Emiel F. M.
Postma, Dirkje S.
RESPIRATORY RESEARCH, 2012, 13
[49] THE EFFECT OF BETA-BLOCKERS ON VENTILATORY FUNCTION IN CHRONIC-BRONCHITIS
RANCHOD, A
KEETON, GR
BENATAR, SR
SOUTH AFRICAN MEDICAL JOURNAL, 1982, 61 (12): : 423 - 424
[50] Beta Blockers and Cardiovascular Risk in Chronic Obstructive Pulmonary Disease
Enrique Machado-Alba, Jorge
Alejandro Medina-Morales, Diego
Maria Banol-Giraldo, Alejandra
Machado-Duque, Manuel E.
REVISTA MEDICA DE CHILE, 2014, 142 (06) : 807 - 808

← 1 2 3 4 5 →